Navamedic ASA: Launch of new products strengthen the category of Medical Nutrition
Oslo June 1[th], 2021 – Navamedic ASA (“Navamedic”, OSE: NAVA) announces the launch of new products in the Nordics.Medical Nutrition is a strategically important area for Navamedic and to further strengthen our presence, we have now launched three new products in this category. The first to be launched is Glycosade Lemon for the dietary treatment of Glycogen Storage Disease (GSD), an inborn error of metabolism. The other two, K.Flo and K.Yo, are both used for the dietary management of drug-resistant epilepsy or other conditions for which a ketogenic diet is indicated. “We are proud to